What was the depreciation expense for Dermani Medspa for the year ended December 31, 2022?

According to Dermani Medspa's 2025 Franchise Disclosure Document, the depreciation expense for the year ended December 31, 2022, was $7,499. Depreciation expense represents the reduction in value of an asset over time, which is a non-cash expense that reflects the wear and tear or obsolescence of Dermani Medspa's assets. This figure is important for understanding the company's overall financial performance and profitability.

For a prospective franchisee, understanding the depreciation expense can provide insights into the capital expenditures Dermani Medspa has made and how these assets are being accounted for. While this specific figure pertains to the franchisor's financial statements, it highlights the importance of considering depreciation when evaluating the financial health of a franchised location. Franchisees may incur similar depreciation expenses on their own equipment and assets, which will impact their profitability.

It's important to note that depreciation is a non-cash expense, meaning it does not involve an actual outflow of cash. However, it does reduce the reported profit of the company, which can affect its tax liability. Franchisees should consult with a financial advisor to understand how depreciation expenses will impact their own financial statements and tax obligations. Understanding these accounting principles is crucial for making informed business decisions and managing the financial aspects of a Dermani Medspa franchise.